Multiple organ dysfunction syndrome (MODS) in the obstetric population

Journal of Perinatal and Neonatal Nursing

Volumn 15, Issue 4, 2002, Pages 37-55

  Curran, Carol A ^a  

^a CNSA/Clinical Nurse Specialists and Associates   (United States)

Author keywords

Critical care obstetrics; Inflammatory mediators; Multiple organ dysfunction syndrome (MODS); Multiple organ failure; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FETAL WELL BEING; HUMAN; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FETAL VIABILITY; HUMANS; MULTIPLE ORGAN FAILURE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0036518181     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200203000-00006     Document Type: Article

References (22)

1. American College of Chest Physicians and Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
2. Secor V. Multiple Organ Dysfunction and Failure: Pathophysiology and Clinical Complications. 2nd ed. St. Louis, MO: Mosby; 1996.
3. Pinsky M. Pathophysiology and therapy of end-organ failure in critical illness. Proc Assoc Am Physicians. 1995;107(3):353-360.
4. Matthay M. Severe sepsis - A new treatment with both anticoagulant and anti-inflammatory properties. N Engl J Med. 2001;344(10) (March 8):759-762.
5. Evans TW, Smithies M. ABC of intensive care: Organ dysfunction. Br Med J. 1999;318(7198):1606-1609.
6. Demling R, LaLonde C, Saldinger P, Knox J. Multiple-organ dysfunction in the surgical patient: Pathophysiology, prevention, and treatment. Curr Probl Surg. 1993;30(4):349-414.
7. Hardaway T. Traumatic shock alias posttrauma critical illness. Am Surg. 2000; 66(3):284-289.
8. Clark S, Cotton D, Lee W et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 1989;161(6, pt. 1):1439-1442.
9. Sibai B. Treatment of hypertension in pregnant women. N Engl J Med. 1996;335 (4):257-264.
10. Dekker G, Sibai B. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol. 1998;179(5):1359-1370.
11. Clark S, Hankins G, Dudley V, Dildy G, Porter T. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol. 1995;172(4, pt. 1):1158-1169.
12. Locksmith G. Amniotic fluid embolism. Obstet Gynecol Clin North Am. 1999;26 (3):435-444.
13. Davies S. Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can J Anesth. 1999;46(5):456-459.
14. Maradny E, Kanayama N, Halim A, Maehara K, Terao T. Endothelin has a role in early pathogenesis of amniotic fluid embolism. Gynecol Invest. 1995;40:14-18.
15. Bass N. Predisposition to multiple organ dysfunction. Crit Care Nurs Q. 1994;16(4):1-7.
16. Cunningham FG, MacDonald PC, Grant NF, et al. Williams Obstetrics. 20th ed. Norwalk, CT: Appleton & Lange; 1997.
17. Cummings R., ed. Textbook of Advanced Cardiac Life Support. New York: American Heart Association; 1997.
18. Pearlman M, Tintinalli J. Emergency Care of the Woman. New York: McGraw-Hill; 1998.
19. deSwiet M. Pulmonary disorders. In Creasy R, Resnick R (Eds). Maternal-Fetal Medicine: Principles and Practice. Philadelphia: WB Saunders, 1994.
20. Luppi C. Cardiopulmonary resuscitation in pregnancy. In Mandeville L, Troiano N. High-Risk and Critical Care Intrapartum Nursing. 2nd ed. Philadelphia: Lippincott; 1999.
21. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699-709.
22. White B, Livingston W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood. 2000; 96(12):3719-3724.